Syncom Formulations

Syncom Formulations

15.45
-0.42
(-2.65%)
hide
Key Fundamentals
Add Ratio
Market Cap
1,452.30 Cr
EPS
0.57
PE Ratio
23.87
Dividend Yield
0.00 %
Industry
Healthcare
52 Week High
23.87
52 Week Low
14.10
PB Ratio
3.97
Debt to Equity
0.12
Forecast For
Actual

Company News

View All News
Caret
positive
Syncom Formulations (India) Limited has successfully acquired the entire 3rd Floor of TradeStar building on Andheri-Kurla Road, Mumbai, from HDFC Bank Ltd. The pharmaceutical company paid ₹51.70 crores as full and final consideration for this commercial property acquisition, which the company considers material in nature.
negative
Syncom Formulations (India) Limited reported quarterly results for the period ended September 30, 2025. The company's revenue from operations decreased to Rs 12,143.51 lakhs compared to Rs 16,546.69 lakhs in the previous quarter. Net profit for the quarter stood at Rs 1,572.93 lakhs, down from Rs 1,695.00 lakhs in the prior quarter. For the half-year period, revenue reached Rs 28,690.20 lakhs versus Rs 18,735.68 lakhs in the corresponding previous period. The company operates in three business segments: Pharmaceuticals, Drugs & Formulations, Trading of Commodities, and Renting of Property. Basic earnings per share for the quarter was Rs 0.18 compared to Rs 0.21 in the previous quarter. The results were approved by the Board of Directors at their meeting held on November 12, 2025.
positive
Syncom Formulations (India) reported quarterly net profit of 166 million rupees compared to 111 million rupees in the same period last year. Revenue increased to 1.2 billion rupees from 1.02 billion rupees year-over-year. EBITDA rose to 184 million rupees from 122 million rupees, while EBITDA margin improved to 15.12% from 11.89% in the previous year.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,780.80
#1 4,27,273.57
40.68
#1 54,729.00
9.71
#1 10,980
2.89
72.13
6,359.00
1,68,811.47
69.05
9,712.00
18.67
2,191
35.10
41.81
3,718.40
1,25,847.55
58.80
11,539.40
6.99
1,911
30.46
54.13
1,504.00
1,22,116.30
22.73
28,409.50
7.12
5,291
3.71
41.45
1,226.20
1,02,340.34
#1 18.15
33,741.20
16.73
5,725
-0.38
44.49
926.65
93,242.67
18.56
23,511.00
18.55
4,615
34.60
33.65
2,222.70
91,743.83
52.05
12,744.20
#1 20.90
2,007
-21.05
31.31
1,999.60
91,332.63
21.34
22,909.50
13.74
3,306
#1 72.75
50.86
1,194.00
69,347.71
20.70
32,345.60
9.43
3,484
3.81
58.49
5,625.00
67,255.31
28.29
13,458.30
3.70
2,216
10.98
49.85
Growth Rate
Revenue Growth
74.21 %
Net Income Growth
95.26 %
Cash Flow Change
493.29 %
ROE
64.39 %
ROCE
45.46 %
EBITDA Margin (Avg.)
-4.87 %

Quarterly Financial Results

Quarterly Financials
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Revenue
53
56
60
64
54
57
59
68
62
68
70
78
89
107
132
156
123
127
Expenses
44
47
52
56
48
50
52
55
53
57
58
65
77
90
113
131
101
103
EBITDA
8
8
7
8
7
7
8
13
8
10
12
13
12
16
19
25
22
24
Operating Profit %
14 %
11 %
9 %
3 %
7 %
8 %
10 %
10 %
11 %
10 %
11 %
13 %
12 %
12 %
12 %
12 %
14 %
15 %
Depreciation
1
1
1
1
1
1
1
1
1
1
2
1
1
1
1
1
1
1
Interest
0
0
0
1
1
1
1
1
1
1
1
1
0
0
0
0
0
0
Profit Before Tax
7
7
6
6
5
5
6
10
6
8
9
10
10
15
17
23
20
22
Tax
2
2
2
1
1
2
2
2
2
2
2
3
3
4
4
6
5
5
Net Profit
5
6
4
5
4
4
4
9
4
7
7
7
8
11
13
18
16
17
EPS in ₹
0.07
0.06
0.07
0.05
0.03
0.06
0.06
0.10
0.07
0.08
0.09
0.10
0.11
0.16
0.14
0.16
0.21
0.18

Balance Sheet

Balance Sheet
2015
2016
2017
2022
2023
2024
2025
Total Assets
138
175
180
308
378
405
413
Fixed Assets
46
46
55
94
91
120
125
Current Assets
79
86
83
140
182
275
270
Capital Work in Progress
0
5
0
6
26
0
0
Investments
0
0
0
43
64
66
93
Other Assets
92
125
125
165
197
219
196
Total Liabilities
138
175
180
308
378
405
413
Current Liabilities
32
60
55
78
113
107
59
Non Current Liabilities
6
6
8
8
9
10
12
Total Equity
100
109
117
222
256
288
342
Reserve & Surplus
22
31
39
131
162
194
248
Share Capital
78
78
78
86
94
94
94

Cash Flow

Cash Flow
2015
2016
2017
2022
2023
2024
2025
Net Cash Flow
2
-1
1
-3
1
63
-63
Investing Activities
1
-23
-18
-27
-45
83
-18
Operating Activities
0
24
14
16
11
-6
23
Financing Activities
1
-2
5
8
35
-15
-68

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Nov 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Promoter
41.18 %
41.18 %
44.01 %
44.01 %
46.12 %
50.57 %
50.57 %
50.57 %
50.57 %
50.57 %
50.57 %
50.57 %
50.57 %
50.57 %
50.57 %
50.57 %
50.57 %
50.57 %
50.57 %
50.57 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.08 %
0.09 %
0.10 %
0.13 %
0.11 %
0.41 %
0.10 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
54.31 %
54.11 %
51.35 %
51.08 %
49.68 %
44.86 %
44.91 %
45.03 %
45.02 %
44.85 %
45.00 %
44.76 %
44.82 %
44.85 %
45.08 %
45.14 %
45.06 %
45.20 %
44.83 %
45.21 %
Others
4.51 %
4.71 %
4.64 %
4.90 %
4.19 %
4.57 %
4.52 %
4.40 %
4.41 %
4.59 %
4.43 %
4.67 %
4.61 %
4.50 %
4.27 %
4.18 %
4.24 %
4.12 %
4.19 %
4.12 %
No of Share Holders
72,450
93,207
1,20,800
1,88,981
2,32,617
2,35,517
2,32,749
2,31,495
2,32,069
2,27,478
2,24,925
2,24,252
2,89,982
3,25,761
3,76,530
4,69,242
4,89,520
4,84,529
4,71,066
4,57,364

Dividend History

Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 0.00 0.00 0.03 0.00 0.00 0.00
Dividend Yield (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.5 0.00 0.00 0.00

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
13 Sept 2022 DIVIDEND Dividend
₹ 0.03 /share
09 Sept 2022 9.18 9.18
26 Sept 2023 ANNUAL GENERAL MEETING Annual General Meeting
NA
26 Sept 2023 9.14 8.50
30 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
30 Sept 2024 23.18 21.98
11 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
11 Nov 2024 20.83 20.49
10 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
10 Feb 2025 18.44 18.44
19 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
19 May 2025 16.44 17.49
08 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
08 Aug 2025 18.01 17.88
29 Sept 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
29 Sept 2025 18.27 16.71
12 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
12 Nov 2025 16.10 16.00

Announcements

Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015 Read With Master SEBI Circular SEBI/HO/CFD/Pod2/CIR/P/0155 Dated 11Th November 2024. 2 days ago
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 13, 2025
Regulation 33(3) Of SEBI (LODR) Regulations 2015 - Submission Of Standalone & Consolidated Unaudited Financial Results .Nov 12, 2025
Board Meeting Outcome for Regulation 33(3) Of SEBI (LODR) Regulations 2015 Submission Of Standalone & Consolidated Unaudited Financial Results Along With Limited Review ReportNov 12, 2025
Board Meeting Intimation for Board Meeting IntimationNov 07, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 16, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementOct 01, 2025
Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of AssociationOct 01, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementOct 01, 2025
Shareholder Meeting / Postal Ballot-Outcome of AGMOct 01, 2025
Shareholder Meeting / Postal Ballot-Scrutinizers ReportOct 01, 2025
Proceedings Of 37Th Annual General MeetingSep 29, 2025
Closure of Trading WindowSep 23, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 06, 2025
Business Responsibility and Sustainability Reporting (BRSR)Sep 04, 2025
Reg. 34 (1) Annual Report.Sep 04, 2025
Notice Of Annual General Meeting Of Syncom Formulations (India) Limited.Sep 04, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 02, 2025
Intimation Regarding 100 Days Campaign - Saksham Niveshak From 28Th July 2025 To 6Th November 2025 Update Your KYC Details And Claim Your Unpaid/ Unclaimed Dividends.Aug 27, 2025
Intimation Regarding 100 Days Campaign - Saksham Niveshak From 28Th July 2025 To 6Th November 2025 Update Your KYC Details And Claim Your Unpaid/ Unclaimed Dividends.Aug 27, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementAug 18, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 09, 2025
Pursuant To Reg 44 SEBI LODR Remote E Voting Facility For 37Th AGMAug 08, 2025
BOOK CLOSURE FOR 37TH AGM TO BE HELD ON 29TH SEPTEMBER 2025Aug 08, 2025
Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of AssociationAug 08, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementAug 08, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementAug 08, 2025
Board Meeting Outcome for Outcome Of The 2/2025-26 Meeting Of The Board Of Directors Of The CompanyAug 08, 2025
Results- Financial Results 30.06.2025Aug 08, 2025
Board Meeting Intimation for Corporate Announcement U/R 29(1)(A) Of SEBI (LODR) Regulations 2015 Read With SEBI (PIT) Regulations 2015 Regarding Intimation Of Holding The 2/2025-26 Board MeetingAug 02, 2025
Dispatch Of KYC Letters To Shareholders Requiring Copy Of Bank Accounts Details Copy Of PAN Card KYC Details And Nomination As Per SEBI Circular.Jul 17, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 08, 2025
Closure of Trading WindowJun 25, 2025
Announcement Under Regulations 30 (LODR)Jun 12, 2025
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 21, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 20, 2025
Results For The Quarter And Year Ended 31.03.2025May 19, 2025
Board Meeting Outcome for Regulation 33(3)(D) Of SEBI (LODR) Regulations 2015-Submission Of Standalone & Consolidated Audited Financial Results Along With Audit Report Statement Of Assets And Liabilities And Cash Flow For The Year Ended On 31St March 2025May 19, 2025
Board Meeting Intimation for Corporate Announcement U/R 29(1)(A) Of SEBI (LODR) Regulations 2015 Read With SEBI (PIT) Regulations 2015 Regarding Intimation Of Holding The 1/2025-26 Board Meeting For The Quarter And Year Ended On 31St March 2025May 13, 2025
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AMay 13, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 17, 2025
Announcement Under Regulation 30Apr 05, 2025
Closure of Trading WindowMar 25, 2025
Disclosure under Regulation 30A of LODRFeb 13, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 11, 2025
Integrated Filing (Financial)Feb 10, 2025
Regulation 33(3) Of SEBI (LODR) Regulations 2015 - Submission Of Standalone & Consolidated Unaudited Financial Results Along With Limited Review Report For The Quarter And Nine Months Ended On 31St DeFeb 10, 2025
Compliances-Reg. 50 (1) - Prior intimation about Board meeting under Regulation 50(1)Feb 03, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 21, 2025
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateNov 26, 2024

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Bandhan BSE Healthcare Index Fund Direct-Growth
0.06%
32
0.00%
0.00%

Technical Indicators

RSI(14)
Neutral
37.03
ATR(14)
Less Volatile
0.42
STOCH(9,6)
Neutral
27.10
STOCH RSI(14)
Oversold
16.70
MACD(12,26)
Bearish
-0.02
ADX(14)
Weak Trend
13.79
UO(9)
Bearish
30.72
ROC(12)
Downtrend And Accelerating
-3.11
WillR(14)
Oversold
-95.17